General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Catonella morbi is a Gram-negative, non-spore-forming, strictly anaerobic, non-motile, rod-shaped bacterium. It has been detected in at least 3 gut microbiome compilation studies or metastudies. The DNA G+C content is 34%. Catonella morbi is probably a rare gut coloniser. (Moore1994a)



  • This organism has been recovered from the gingival crevices of humans with adult periodontitis. The risk classification (www.baua.de) for this organism is 2, i.e., risk of individual infection, but low risk of spread. It is an opportunistic pathogen. A possible gut commensal.

  • GENERAL CHARACTERISTICS (Moore1994a);
    Character Response
  • Substrates hydrolysed or digested:
  • aesculin; starch;
  • ±
  • Strain-dependent hydrolysis or digestion:
  • gelatin; milk;
  • 💧
  • Bile tolerance:
  • Sensitive(20)
  • H+
  • Acid from carbohydrates usually produced:
  • glucose; rhamnose; raffinose; sucrose;
  • ±
  • Strain-dependent acid from carbs:
  • amygdalin; dextrin; glycogen; cellubiose; lactose; maltose; melibiose; trehalose; salicin;

  • SPECIAL FEATURES (Moore1994a);
    Character Response
  • Metabolites produced:
  • formate; acetate; lactate; H₂;
  • Metabolites not produced:
  • H₂S; indole;
  • Haemolysis:
  • absent
  • Nitrate:
  • not reduced

  • RESPONSE TO ANTIBIOTICS (Moore1994a);
    Class Active Resistant
  • Penicillins:
  • penicillin;
  • Macrolides:
  • erythromycin;
  • Tetracyclines:
  • tetracycline;
  • Heterocycles:
  • chloramphenicol;
  • Miscellaneous antibiotics:
  • clindamycin;

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Clostridia Order:  Eubacteriales Family:  Lachnospiraceae Genus:  Catonella Gram stain:  neg O2 Relation.:  strictly anaerobic Spore:  No spore Motility:  Sessile Morphology:  Rod
    Health:  Unknown
    Source:  the gingival crevices of humans with adult periodontitis
    DNA G+C(%):  34
    Bile reaction(%):  S(20)
    Aesculin:  + Gelatin:  d(neg) Starch:  d(+) Milk:  curdles Meat:  neg

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Arabinose:  neg Fructose:  neg Glucose:  d(+) Mannose:  neg Rhamnose:  d(+) Ribose:  neg Xylose:  neg Cellubiose:  d Lactose:  d Maltose:  d Melezitose:  neg Melibiose:  d(neg) Sucrose:  + Trehalose:  d(neg) Amygdalin:  d(neg) Dextrin:  d Aesculin:  neg Glycogen:  d Inulin:  neg Starch:  neg Pectin:  neg Erythritol:  neg Mannitol:  neg Sorbitol:  neg Salicin:  d(neg)

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Catalase:  neg Lecithinase:  neg Lipase:  neg

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Formate:  + Acetate:  + Lactate:  + H2S:  neg H2:  + Indole:  neg

    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    penicillin:  S(2U)
    erythromycin:  S(3)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  S(6)
    chloramphenicol:  S(12)
    clindamycin:  S(1.6)

    References


    SPECIFIC REFERENCES FOR CATONELLA MORBI
  • Moore1994a - Oribaculum catoniae gen. nov., sp. nov.: Catonella morbi gen. nov., sp. nov.: Hallella seregens gen. nov., sp. nov.: Johnsonella ignava gen. nov., sp. nov.: and Dialister pneumosintes gen. nov., comb. nov., nom. rev., Anaerobic Gram-Negative Bacilli from the Human Gingival Crevice.
  • Willems1995b - Evidence for the placement of the gram-negative Catonella morbi (Moore and Moore) and Johnsonella ignava (Moore and Moore) within the Clostridium subphylum of the gram-positive bacteria on the basis of 16S rRNA sequences.
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR CATONELLA MORBI
  • Byrd2020 - Stability and dynamics of the human gut microbiome and its association with systemic immune traits.
  • Zeller2014 - Potential of fecal microbiota for early-stage detection of colorectal cancer
  • ...............................